Showing 1 - 18 results of 18 for search 'Timo Rath', query time: 0.07s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study. by Victoria Klotter, Caroline Gunchick, Enno Siemers, Timo Rath, Helge Hudel, Lutz Naehrlich, Martin Roderfeld, Elke Roeb
Published 2017-01-01
Article -
9
-
10
-
11
Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy by Christian Bojarski, Maximilian Waldner, Timo Rath, Sebastian Schürmann, Markus F. Neurath, Markus F. Neurath, Raja Atreya, Raja Atreya, Britta Siegmund
Published 2021-07-01
Article -
12
Systemic and mucosal immune reactivity upon Mycobacterium avium ssp. paratuberculosis infection in mice. by Arzu Koc, Imke Bargen, Abdulhadi Suwandi, Martin Roderfeld, Annette Tschuschner, Timo Rath, Gerald F Gerlach, Mathias Hornef, Ralph Goethe, Siegfried Weiss, Elke Roeb
Published 2014-01-01
Article -
13
Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis by Ingo Ganzleben, Carol Geppert, Lourdes Osaba, Simon Hirschmann, Andreas Nägel, Christian Glück, Arthur Hoffman, Timo Rath, Daniel Nagore, Markus F. Neurath, Raja Atreya
Published 2020-10-01
Article -
14
Long-term outcomes of cyclosporin induction and ustekinumab maintenance combination therapy in patients with steroid-refractory acute severe ulcerative colitis by Francesco Vitali, Timo Rath, Entcho Klenske, Anna-Lena Vögele, Ingo Ganzleben, Sebastian Zundler, Deike Strobel, Carol Geppert, Arndt Hartmann, Markus F. Neurath, Raja Atreya
Published 2024-01-01
Article -
15
Healing of the epithelial barrier in the ileum is superior to endoscopic and histologic remission for predicting major adverse outcomes in ulcerative colitis by Timo Rath, Raja Atreya, Julia Bodenschatz, Wolfgang Uter, Carol I. Geppert, Francesco Vitali, Sebastian Zundler, Maximilian J. Waldner, Arndt Hartmann, Markus F. Neurath, Markus F. Neurath
Published 2023-10-01
Article -
16
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab by Sarah Fischer, Sarah Cohnen, Entcho Klenske, Heike Schmitt, Francesco Vitali, Simon Hirschmann, Andreas Ramming, Sebastian Zundler, Timo Rath, Sabine Krebs, Frank Dörje, Wolfgang Uter, Daniel Nagore, Sebastian Meyer, Markus F. Neurath, Raja Atreya
Published 2021-01-01
Article -
17
Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort s... by Sarah Fischer, Moritz Donhauser, Sarah Cohnen, Konstantin Fietkau, Marcel Vetter, Maria Grübel-Liehr, Peter Dietrich, Timo Rath, Angelika Wilfer, Ludmilla Sologub, Sabine Krebs, Frank Dörje, Daniel Nagore, Sebastian Meyer, Markus F. Neurath, Raja Atreya
Published 2024-11-01
Article -
18
IL-13 as Target to Reduce Cholestasis and Dysbiosis in <i>Abcb4</i> Knockout Mice by Luisa Hahn, Nora Helmrich, Diran Herebian, Ertan Mayatepek, Uta Drebber, Eugen Domann, Stefan Olejniczak, Markus Weigel, Torsten Hain, Timo Rath, Stefan Wirtz, Hans-Joachim Mollenkopf, Nadine Schmidt, Christa Ewers, Anne Baier, Yuri Churin, Anita Windhorst, Ralf Weiskirchen, Ulrich Steinhoff, Elke Roeb, Martin Roderfeld
Published 2020-08-01
Article